![Todd Simpson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Simpson
Directeur/Membre du Conseil chez
XENCOR, INC.
Fortune : - $ au 31/05/2026
Profil
Todd E. Simpson est actuellement président de Neoleukin Therapeutics, Inc. et directeur financier de Seagen Inc. M. Simpson est également membre du conseil d'administration de Cascadian Therapeutics, Inc. et de la Washington Biotechnology & Biomedical Association. Dans sa carrière antérieure, il a occupé les postes de directeur financier et de vice-président des finances et de l'administration chez Vericel Corp, de trésorier chez Integra LifeSciences Holdings Corp et de directeur financier et vice-président de Telios Pharmaceuticals, Inc. (une filiale d'Integra LifeSciences Holdings Corp.), directeur financier et vice-président des finances et de l'administration chez AmpliPhi Biosciences Corp. et directeur chez Ernst & Young LLP. Il est titulaire d'un diplôme de premier cycle de l'université d'État de l'Oregon.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XENCOR, INC. -.--% | 28/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Dernières actualités sur Todd Simpson
Postes actifs de Todd Simpson
| Sociétés | Poste | Début |
|---|---|---|
| XENCOR, INC. | Directeur/Membre du Conseil | 13/03/2025 |
Shape Therapeutics, Inc.
 Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Directeur/Membre du Conseil | 25/06/2024 |
Inovia Capital (US), Inc.
 Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Consultant / Advisor | 01/01/2017 |
Anciens postes connus de Todd Simpson
| Sociétés | Poste | Fin |
|---|---|---|
| SEAGEN INC. | Directeur Financier/CFO | 14/12/2022 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Directeur Financier/CFO | 01/10/2005 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Directeur Financier/CFO | 01/10/2001 |
| VERICEL CORPORATION | Directeur Financier/CFO | 01/10/2001 |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Treasurer | 01/12/1995 |
Formation de Todd Simpson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Telios Pharmaceuticals, Inc.
 Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, research | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Oregon State University
 Oregon State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Inovia Capital (US), Inc.
Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Health Technology |
Neoleukin Therapeutics, Inc. /old/
 Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops medicines that transform lives | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
